Lisa Lynn Decker's Insider Trades & SAST Disclosures
Lisa Lynn Decker's most recent trade in IGM Biosciences Inc was a trade of 4,512 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on March 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lisa Lynn Decker.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 14 Mar 2025 | 4,512 | 73,529 (0%) | 0% | 1.2 | 5,550 | Common Stock |
| IGM Biosciences Inc | Lynn Lisa Decker | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 7.48 per share. | 16 Dec 2024 | 1,063 | 78,041 (0%) | 0% | 7.5 | 7,951 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 11.54 per share. | 13 Sep 2024 | 925 | 79,104 (0%) | 0% | 11.5 | 10,673 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Jul 2024 | 60,000 | 0 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 16,666 | 76,695 (0%) | 0% | - | Common Stock | |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 3,334 | 80,029 (0%) | 0% | - | Common Stock | |
| Chimerix Inc | Lisa Lynn Decker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 14 Jun 2024 | 977 | 60,029 (0%) | 0% | 7.6 | 7,401 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 9.88 per share. | 13 Mar 2024 | 1,798 | 62,584 (0%) | 0% | 9.9 | 17,756 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 10.17 per share. | 13 Mar 2024 | 1,578 | 61,006 (0%) | 0% | 10.2 | 16,049 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 57,500 | 57,500 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Lisa Lynn Decker | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 28,750 | 64,382 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 5.78 per share. | 13 Dec 2023 | 4,369 | 35,632 (0%) | 0% | 5.8 | 25,245 | Common Stock |
| IGM Biosciences Inc | Lynn Lisa Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 6.21 per share. | 29 Nov 2023 | 1,180 | 40,001 (0%) | 0% | 6.2 | 7,331 | 11/29/2023 |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 23 May 2023 | 1,244 | 41,196 (0%) | 0% | 12.3 | 15,302 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 11.71 per share. | 23 May 2023 | 961 | 42,440 (0%) | 0% | 11.7 | 11,253 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 23 May 2023 | 15 | 41,181 (0%) | 0% | 13 | 195 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 8,497 | 41,479 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 16,250 | 32,982 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 18.73 per share. | 14 Mar 2023 | 1,061 | 16,732 (0%) | 0% | 18.7 | 19,875 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 18.77 per share. | 16 Dec 2022 | 1,598 | 18,679 (0%) | 0% | 18.8 | 30,002 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 19.36 per share. | 16 Dec 2022 | 886 | 17,793 (0%) | 0% | 19.4 | 17,153 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 21.38 per share. | 23 Nov 2022 | 861 | 20,674 (0%) | 0% | 21.4 | 18,405 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 21.99 per share. | 23 Nov 2022 | 397 | 20,277 (0%) | 0% | 22.0 | 8,731 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 17.10 per share. | 24 May 2022 | 1,362 | 21,535 (0%) | 0% | 17.1 | 23,293 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 12.38 per share. | 13 May 2022 | 413 | 22,897 (0%) | 0% | 12.4 | 5,113 | Common Stock |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 4,617 | 22,484 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 7,500 | 17,867 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 50.99 per share. | 15 Nov 2021 | 367 | 367 (0%) | 0% | 51.0 | 18,713 | Common Stock |
| Atreca Inc - Ordinary Shar... | Lisa Lynn Decker | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 80,000 | 80,000 | - | - | Employee stock option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges